https://thelifesciencefeed.com/oncology/prostatic-neoplasms/insights/proteus-trial-neoadjuvant-apalutamide-adt-high-risk-prostate-cancer The Life Science Feed en 2026-06-12T09:04:26Z PROTEUS Trial: Neoadjuvant Apalutamide Plus ADT in High-Risk Prostate Cancer https://thelifesciencefeed.com/oncology/lung-neoplasms/research/targeted-adcs-for-advanced-lung-cancer The Life Science Feed en 2026-05-29T00:00:00Z Targeted ADCs For Advanced Lung Cancer https://thelifesciencefeed.com/rheumatology/arthritis-rheumatoid/research/stopping-spinal-fusion-or-protecting-the-gut The Life Science Feed en 2026-06-01T00:00:00Z Stopping Spinal Fusion Or Protecting The Gut? https://thelifesciencefeed.com/rheumatology/arthritis-rheumatoid/practice/chasing-absolute-zero-in-rheumatoid-arthritis The Life Science Feed en 2026-06-01T00:00:00Z Chasing Absolute Zero In Rheumatoid Arthritis https://thelifesciencefeed.com/cardiology/heart-failure/practice/managing-acute-heart-failure-and-cardiogenic-shock The Life Science Feed en 2026-06-01T00:00:00Z Managing Acute Heart Failure And Cardiogenic Shock https://thelifesciencefeed.com/oncology/melanoma/innovation/car-t-therapy-versus-bispecific-antibodies The Life Science Feed en 2026-06-01T00:00:00Z CAR-T Therapy Versus Bispecific Antibodies https://thelifesciencefeed.com/oncology/melanoma/insights/small-molecules-vs-car-t-in-cll The Life Science Feed en 2026-06-01T00:00:00Z Small Molecules VS CAR-T In CLL https://thelifesciencefeed.com/oncology/solid-tumors/innovation/car-t-masterstroke-or-biological-chaos The Life Science Feed en 2026-06-01T00:00:00Z CAR-T Masterstroke Or Biological Chaos? https://thelifesciencefeed.com/neurology/alzheimer-disease/research/why-new-alzheimers-drugs-make-brains-bleed The Life Science Feed en 2026-06-12T09:04:20Z Why New Alzheimer's Drugs Make Brains Bleed? https://thelifesciencefeed.com/oncology/lung-neoplasms/research/how-immunotherapy-unmasks-invisible-lung-cancer The Life Science Feed en 2026-05-29T00:00:00Z How Immunotherapy Unmasks Invisible Lung Cancer https://thelifesciencefeed.com/cardiology/heart-failure/research/diabetes-drugs-for-stiff-heart-failure The Life Science Feed en 2026-06-01T00:00:00Z Diabetes Drugs For Stiff Heart Failure https://thelifesciencefeed.com/neurology/alzheimer-disease/research/amyloid-hypothesis-finally-validated-dementia-ep1 The Life Science Feed en 2026-06-12T09:04:20Z The Amyloid Hypothesis, Finally Validated? https://thelifesciencefeed.com/cardiology/heart-failure/research/semaglutide-for-obese-heart-failure-patients The Life Science Feed en 2026-06-01T00:00:00Z Semaglutide For Obese Heart Failure Patients https://thelifesciencefeed.com/rheumatology/arthritis-rheumatoid/insights/the-oral-surveillance-jak-inhibitor-controversy The Life Science Feed en 2026-06-01T00:00:00Z The ORAL Surveillance JAK Inhibitor Controversy https://thelifesciencefeed.com/cardiology/heart-failure/insights/how-four-drugs-beat-heart-failure The Life Science Feed en 2026-06-01T00:00:00Z How Four Drugs Beat Heart Failure https://thelifesciencefeed.com/oncology/melanoma/innovation/moving-car-t-to-earlier-myeloma-lines The Life Science Feed en 2026-06-01T00:00:00Z Moving CAR-T To Earlier Myeloma Lines https://thelifesciencefeed.com/rheumatology/arthritis-rheumatoid/insights/why-cheaper-humira-alternatives-face-resistance The Life Science Feed en 2026-06-01T00:00:00Z Why Cheaper Humira Alternatives Face Resistance https://thelifesciencefeed.com/endocrinology/obesity/news/glp-1-drugs-protect-hearts-and-kidneys The Life Science Feed en 2026-05-28T00:00:00Z GLP-1 Drugs Protect Hearts And Kidneys https://thelifesciencefeed.com/dermatology/plaque-psoriasis/insights/is-it-safe-to-switch-biosimilars The Life Science Feed en 2026-06-12T09:04:19Z Is It Safe To Switch Biosimilars? https://thelifesciencefeed.com/endocrinology/obesity/insights/the-glp-1-muscle-loss-dilemma The Life Science Feed en 2026-05-28T00:00:00Z The GLP-1 Muscle Loss Dilemma https://thelifesciencefeed.com/oncology/lung-neoplasms/innovation/outsmarting-shape-shifting-lung-cancer-resistance The Life Science Feed en 2026-05-30T00:00:00Z Outsmarting Shape-Shifting Lung Cancer Resistance https://thelifesciencefeed.com/dermatology/plaque-psoriasis/insights/psoriasis-monitoring-landscape-guide The Life Science Feed en 2026-06-12T09:04:19Z Psoriasis Monitoring Landscape Guide https://thelifesciencefeed.com/oncology/lung-neoplasms/innovation/hacking-the-lung-cancer-genetic-code The Life Science Feed en 2026-05-29T00:00:00Z Hacking the Lung Cancer Genetic Code https://thelifesciencefeed.com/dermatology/plaque-psoriasis/insights/why-half-of-psoriasis-patients-quit The Life Science Feed en 2026-05-28T00:00:00Z Why Half Of Psoriasis Patients Quit https://thelifesciencefeed.com/dermatology/plaque-psoriasis/innovation/replacing-biologic-injections-with-oral-pills The Life Science Feed en 2026-06-12T09:04:19Z Replacing Biologic Injections With Oral Pills https://thelifesciencefeed.com/endocrinology/obesity/innovation/rewiring-the-brain-to-silence-food-noise The Life Science Feed en 2026-05-28T00:00:00Z Rewiring The Brain To Silence Food Noise https://thelifesciencefeed.com/endocrinology/obesity/insights/the-velvet-rope-of-weight-loss-drugs The Life Science Feed en 2026-05-28T00:00:00Z The Velvet Rope Of Weight Loss Drugs https://thelifesciencefeed.com/haematology/multiple-myeloma/news/novel-approaches-address-multiple-myeloma-resistance-eha-2026 The Life Science Feed en 2026-06-12T00:00:00Z Novel Approaches Address Multiple Myeloma Resistance at EHA 2026 https://thelifesciencefeed.com/haematology/lymphoma/guidelines/car-t-cell-therapy-guidelines-eha-2026-lymphoma-myeloma The Life Science Feed en 2026-06-12T00:00:00Z CAR T-Cell Therapy Guidelines Evolve for Lymphoma, Myeloma at EHA 2026 https://thelifesciencefeed.com/neurology/alzheimer-disease/research/targeting-tau-inflammation-and-alzheimers-metabolism The Life Science Feed en 2026-06-12T08:59:51Z Targeting Tau Inflammation And Alzheimer's Metabolism https://thelifesciencefeed.com/neurology/alzheimer-disease/research/preventing-45-percent-of-dementia-cases The Life Science Feed en 2026-06-12T08:35:06Z Preventing 45 Percent Of Dementia Cases https://thelifesciencefeed.com/haematology/leukemia/news/flt3mut-aml-outcomes-eha-2026-reviews-current-strategies The Life Science Feed en 2026-06-12T00:00:00Z FLT3mut+ AML Outcomes: EHA 2026 Reviews Current Strategies https://thelifesciencefeed.com/haematology/lymphoma/case/dlbcl-management-bispecific-antibodies-emerging-therapeutic-option The Life Science Feed en 2026-06-12T00:00:00Z DLBCL Management: Bispecific Antibodies as Emerging Therapeutic Option https://thelifesciencefeed.com/haematology/leukemia/research/cll-first-line-treatment-btk-inhibitors-vs-venetoclax-combinations The Life Science Feed en 2026-06-12T00:00:00Z CLL First-Line Treatment: BTK Inhibitors vs. Venetoclax Combinations https://thelifesciencefeed.com/haematology/leukemia/research/btk-inhibitors-cll-evolving-landscape-sequential-strategies The Life Science Feed en 2026-06-12T00:00:00Z BTK Inhibitors in CLL: Evolving Landscape and Sequential Strategies https://thelifesciencefeed.com/haematology/immune-thrombocytopenia/insights/itp-management-bridging-clinician-patient-perspectives The Life Science Feed en 2026-06-12T00:00:00Z ITP Management: Bridging Clinician and Patient Perspectives https://thelifesciencefeed.com/haematology/multiple-myeloma/research/ndmm-treatment-optimisation-communication-individualisation The Life Science Feed en 2026-06-12T00:00:00Z NDMM Treatment Optimisation: Communication Key to Individualisation https://thelifesciencefeed.com/haematology/lymphoma/research/cd20-targeted-therapies-remain-central-to-nhl-management The Life Science Feed en 2026-06-12T00:00:00Z CD20-Targeted Therapies Remain Central to NHL Management https://thelifesciencefeed.com/haematology/myelodysplastic-syndromes/research/optimizing-frontline-lr-mds-treatment-eha-2026-data-review The Life Science Feed en 2026-06-12T00:00:00Z Optimizing Frontline LR-MDS Treatment: EHA 2026 Data Review https://thelifesciencefeed.com/haematology/lymphoma/news/infection-prevention-critical-in-hematological-malignancies The Life Science Feed en 2026-06-12T00:00:00Z Infection Prevention Critical in Hematological Malignancies https://thelifesciencefeed.com/haematology/multiple-myeloma/research/bispecific-antibodies-show-promise-in-relapsedrefractory-multiple-myeloma The Life Science Feed en 2026-06-12T00:00:00Z Bispecific Antibodies Show Promise in Relapsed/Refractory Multiple Myeloma https://thelifesciencefeed.com/haematology/leukemia/research/evolving-infection-prevention-hsct-cellular-therapies The Life Science Feed en 2026-06-12T00:00:00Z Evolving Infection Prevention in HSCT and Cellular Therapies https://thelifesciencefeed.com/haematology/lymphoma/research/allogeneic-cell-therapy-ebv-ptld-eha-2026-insights The Life Science Feed en 2026-06-12T00:00:00Z Allogeneic Cell Therapy for EBV+ PTLD: EHA 2026 Insights https://thelifesciencefeed.com/haematology/leukemia/research/aml-fitness-not-age-intensive-chemotherapy-eligibility The Life Science Feed en 2026-06-12T00:00:00Z AML: Fitness, Not Age, Predicts Intensive Chemotherapy Eligibility https://thelifesciencefeed.com/haematology/leukemia/research/cll-patient-priorities-targeted-therapy-eha-2026 The Life Science Feed en 2026-06-12T00:00:00Z CLL: Aligning Patient Priorities with Targeted Therapy at EHA 2026 https://thelifesciencefeed.com/haematology/myeloproliferative-disorders/research/myelofibrosis-management-cytopenia-eha-2026 The Life Science Feed en 2026-06-12T00:00:00Z Myelofibrosis Management: Cytopenia Guides Treatment at EHA 2026 https://thelifesciencefeed.com/haematology/lymphoma/research/car-t-speed-reliability-patient-outcomes-eha-2026 The Life Science Feed en 2026-06-12T00:00:00Z CAR T: Speed and Reliability Critical for Patient Outcomes https://thelifesciencefeed.com/rheumatology/arthritis-rheumatoid/research/ra-patients-face-elevated-fracture-risk-eular-2026-highlights The Life Science Feed en 2026-06-04T00:00:00Z RA Patients Face Elevated Fracture Risk: EULAR 2026 Highlights https://thelifesciencefeed.com/general-practice/preventive-health-services/news/federal-research-supports-lower-drinking-limits-for-health The Life Science Feed en 2026-06-11T16:20:59Z Federal Research Supports Lower Drinking Limits for Health https://thelifesciencefeed.com/endocrinology/diabetes-mellitus-type-2/news/orforglipron-phase-3-trials-show-efficacy-in-t2d-management The Life Science Feed en 2026-06-11T16:20:35Z Orforglipron Phase 3 Trials Show Efficacy in T2D Management https://thelifesciencefeed.com/oncology/brain-neoplasms/insights/ctdna-predicts-relapse-in-early-cancer-but-clinical-action-remains-unclear The Life Science Feed en 2026-06-11T16:20:07Z ctDNA Predicts Relapse in Early Cancer, but Clinical Action Remains Unclear https://thelifesciencefeed.com/endocrinology/diabetes-mellitus-type-2/research/acupuncture-reduces-insulin-needs-in-type-2-diabetes The Life Science Feed en 2026-06-11T16:19:43Z Acupuncture Reduces Insulin Needs in Type 2 Diabetes https://thelifesciencefeed.com/infectious-diseases/covid19/news/c-difficile-hospital-deaths-rose-during-covid-19-pandemic The Life Science Feed en 2026-06-11T16:19:13Z C. difficile Hospital Deaths Rose During COVID-19 Pandemic https://thelifesciencefeed.com/obstetrics-and-gyn/pregnancy-complications/guidelines/acog-simplifies-maternal-immunisation-schedule-for-gps The Life Science Feed en 2026-06-11T16:18:51Z ACOG Simplifies Maternal Immunisation Schedule for GPs https://thelifesciencefeed.com/nephrology/chronic-kidney-disease/research/waist-size-muscle-mass-predict-ckd-prognosis-mortality-risk The Life Science Feed en 2026-06-11T16:18:04Z Waist Size, Muscle Mass Predict CKD Prognosis, Mortality Risk https://thelifesciencefeed.com/dermatology/plaque-psoriasis/research/psoriasis-chronic-intense-pain-multiple-sites The Life Science Feed en 2026-06-11T16:17:33Z Psoriasis Patients Report Chronic Intense Pain, Multiple Pain Sites https://thelifesciencefeed.com/genetics/gene-therapy/innovation/exosomes-emerge-as-cell-free-option-in-regenerative-medicine The Life Science Feed en 2026-06-11T16:17:12Z Exosomes Emerge as Cell-Free Option in Regenerative Medicine https://thelifesciencefeed.com/pain-and-palliative-care/neuralgia/research/dexamethasone-offers-no-benefit-in-headache-after-occipital-nerve-block The Life Science Feed en 2026-06-11T16:16:49Z Dexamethasone Offers No Benefit in Headache After Occipital Nerve Block https://thelifesciencefeed.com/healthcare-sys-and-biz/health-policy/news/patient-debt-complicates-doctor-patient-relationships-care-decisions The Life Science Feed en 2026-06-11T16:16:19Z Patient Debt Complicates Doctor-Patient Relationships, Care Decisions https://thelifesciencefeed.com/haematology/lymphoma/research/allogeneic-cell-therapy-ebv-ptld-eha-2026 The Life Science Feed en 2026-06-11T00:00:00Z Allogeneic Cell Therapy for EBV+ PTLD: EHA 2026 Insights https://thelifesciencefeed.com/haematology/leukemia/innovation/novel-therapies-improve-outcomes-post-cbtki-cll-eha-2026 The Life Science Feed en 2026-06-11T00:00:00Z Novel Therapies Improve Outcomes Post-cBTKi in CLL at EHA 2026 https://thelifesciencefeed.com/haematology/lymphoma/research/bispecific-antibodies-relapsed-follicular-lymphoma The Life Science Feed en 2026-06-11T00:00:00Z Bispecific Antibodies Positioned in Relapsed Follicular Lymphoma https://thelifesciencefeed.com/haematology/leukemia/research/cml-survivorship-beyond-survival-to-quality-of-life The Life Science Feed en 2026-06-11T00:00:00Z CML Survivorship: Beyond Survival to Quality of Life https://thelifesciencefeed.com/immunology/immune-thrombocytopenia/research/immune-drivers-autoimmune-cytopenias-patient-care The Life Science Feed en 2026-06-11T00:00:00Z Immune Drivers in Autoimmune Cytopenias Inform Patient Care https://thelifesciencefeed.com/haematology/lymphoma/news/car-t-therapy-sustained-efficacy-relapsed-refractory-lymphoma-eha-2026 The Life Science Feed en 2026-06-11T00:00:00Z CAR T Therapy Shows Sustained Efficacy in Relapsed/Refractory Lymphoma https://thelifesciencefeed.com/haematology/lymphoma/insights/dlbcl-treatment-emerging-targeted-therapies-eha-2026 The Life Science Feed en 2026-06-11T00:00:00Z DLBCL Treatment: Emerging Targeted Therapies at EHA 2026 https://thelifesciencefeed.com/haematology/immune-thrombocytopenia/research/caplacizumab-improves-ittp-outcomes-real-world The Life Science Feed en 2026-06-11T00:00:00Z Caplacizumab Improves iTTP Outcomes in Real-World Settings https://thelifesciencefeed.com/haematology/leukemia/research/aml-fitness-not-age-predicts-ic-eligibility-eha-2026 The Life Science Feed en 2026-06-11T00:00:00Z AML: Fitness, Not Age, Predicts IC Eligibility at EHA 2026 https://thelifesciencefeed.com/haematology/multiple-myeloma/research/bcma-directed-therapies-relapsed-refractory-multiple-myeloma-eha-2026 The Life Science Feed en 2026-06-11T00:00:00Z BCMA-Directed Therapies Show Efficacy in Relapsed/Refractory Multiple Myeloma https://thelifesciencefeed.com/haematology/lymphoma/research/car-t-dlbcl-patient-outcomes-eha-2026 The Life Science Feed en 2026-06-11T00:00:00Z CAR T in DLBCL: Optimising Patient Outcomes at EHA 2026 https://thelifesciencefeed.com/haematology/multiple-myeloma/research/novel-approaches-r-r-mm-eha-2026 The Life Science Feed en 2026-06-11T00:00:00Z Novel Approaches in R/R MM: Expert Perspectives from EHA 2026 https://thelifesciencefeed.com/haematology/myeloproliferative-disorders/research/iron-status-erythrocytosis-symptoms-polycythemia-vera-eha-2026 The Life Science Feed en 2026-06-11T00:00:00Z Iron Status Clarifies Erythrocytosis, Symptoms in Polycythemia Vera https://thelifesciencefeed.com/haematology/multiple-myeloma/research/cd38-mab-quad-therapy-subcutaneous-dosing-reduces-burden The Life Science Feed en 2026-06-11T00:00:00Z CD38 mAb Quad Therapy: Subcutaneous Dosing Reduces Burden https://thelifesciencefeed.com/haematology/lymphoma/research/dlbcl-treatment-sequencing-eha-2026-current-therapies The Life Science Feed en 2026-06-11T00:00:00Z DLBCL Treatment Sequencing: EHA 2026 Explores Current Therapies https://thelifesciencefeed.com/haematology/sickle-cell-disease/research/real-world-data-confirms-proximal-complement-inhibition-in-pnh The Life Science Feed en 2026-06-11T00:00:00Z Real-World Data Confirms Proximal Complement Inhibition in PNH https://thelifesciencefeed.com/haematology/leukemia/case/cll-first-line-therapy-case-based-eha-2026 The Life Science Feed en 2026-06-11T00:00:00Z CLL First-Line Therapy: Case-Based Insights from EHA 2026 https://thelifesciencefeed.com/haematology/multiple-myeloma/insights/multiple-myeloma-aligning-innovation-clinical-practice-eha-2026 The Life Science Feed en 2026-06-11T00:00:00Z Multiple Myeloma: Aligning Innovation with Clinical Practice at EHA 2026 https://thelifesciencefeed.com/haematology/immune-thrombocytopenia/case/rare-conditions-eha-2026-highlights-diagnostic-challenges The Life Science Feed en 2026-06-11T00:00:00Z Rare Conditions: EHA 2026 Highlights Diagnostic Challenges https://thelifesciencefeed.com/haematology/sickle-cell-disease/research/inflammation-drives-sickle-cell-disease-pathophysiology The Life Science Feed en 2026-06-10T10:12:41Z Inflammation Drives Sickle Cell Disease Pathophysiology https://thelifesciencefeed.com/haematology/myeloproliferative-disorders/research/avapritinib-improves-outcomes-nonadvanced-advanced-systemic-mastocytosis The Life Science Feed en 2026-06-10T10:08:10Z Avapritinib Improves Outcomes in Nonadvanced and Advanced Systemic Mastocytosis https://thelifesciencefeed.com/haematology/leukemia/research/flt3-inhibitors-aml-outcomes-transplant The Life Science Feed en 2026-06-10T10:07:46Z FLT3 Inhibitors Improve AML Outcomes Pre- and Post-Transplant https://thelifesciencefeed.com/haematology/leukemia/research/idh1m-aml-ivosidenib-azacitidine-improves-os The Life Science Feed en 2026-06-10T10:07:25Z IDH1m AML: Ivosidenib Plus Azacitidine Improves OS by 12.5 Months https://thelifesciencefeed.com/haematology/lymphoma/innovation/ai-hematology-eha-2026-practical-ethical-integration The Life Science Feed en 2026-06-10T10:07:07Z AI in Hematology: EHA 2026 Focuses on Practical, Ethical Integration https://thelifesciencefeed.com/haematology/multiple-myeloma/practice/bcma-bispecifics-community-myeloma-care-eha-2026 The Life Science Feed en 2026-06-10T10:06:46Z BCMA Bispecifics Transition to Community Myeloma Care: EHA 2026 https://thelifesciencefeed.com/haematology/myelodysplastic-syndromes/research/aml-rethinking-intensive-therapy-myelodysplasia-therapy-related The Life Science Feed en 2026-06-10T10:06:26Z AML: Rethinking Intensive Therapy for Myelodysplasia-Related & Therapy-Related Subtypes https://thelifesciencefeed.com/haematology/lymphoma/research/bispecific-antibodies-fl-eha-2026-advancing-outcomes The Life Science Feed en 2026-06-10T10:05:49Z Bispecific Antibodies in FL: EHA 2026 Explores Advancing Outcomes https://thelifesciencefeed.com/haematology/multiple-myeloma/research/mrd-status-guides-first-line-treatment-duration-haematologic-malignancies The Life Science Feed en 2026-06-10T10:05:25Z MRD Status Guides First-Line Treatment Duration in Haematologic Malignancies https://thelifesciencefeed.com/haematology/leukemia/case/aml-treatment-strategies-optimising-outcomes The Life Science Feed en 2026-06-10T10:05:05Z AML Treatment Strategies: Optimising Outcomes in a Complex Disease https://thelifesciencefeed.com/haematology/multiple-myeloma/news/bispecific-antibodies-relapsed-refractory-haematological-malignancies The Life Science Feed en 2026-06-10T10:04:41Z Bispecific Antibodies Show Promise in Relapsed/Refractory Haematological Malignancies https://thelifesciencefeed.com/haematology/leukemia/insights/cll-eha-2026-unmet-needs-treatment-selection The Life Science Feed en 2026-06-10T10:04:23Z CLL: EHA 2026 to Address Unmet Needs in Treatment Selection https://thelifesciencefeed.com/haematology/sickle-cell-disease/insights/optimising-transplant-haemoglobinopathies-eha-2026-perspectives The Life Science Feed en 2026-06-10T10:04:05Z Optimising Transplant in Haemoglobinopathies: EHA 2026 Perspectives https://thelifesciencefeed.com/haematology/myeloproliferative-disorders/news/jak-inhibitor-combinations-myelofibrosis-eha-2026 The Life Science Feed en 2026-06-10T10:03:45Z JAK Inhibitor Combinations Show Efficacy in Myelofibrosis at EHA 2026 https://thelifesciencefeed.com/haematology/lymphoma/insights/dlbcl-relapse-eha-2026-addresses-gaps-in-treatment-strategy The Life Science Feed en 2026-06-10T10:03:27Z DLBCL Relapse: EHA 2026 Addresses Gaps in Treatment Strategy